IL1B and dermatitis: Research has shown that in AD model mice, the expression level of IL-1β is significantly upregulated, which disrupts the skin barrier and exacerbates skin inflammation by promoting the production of other inflammatory cytokines such as tumor necrosis factor alpha and interleukin 6 [45].